Bruce G. Allen Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$812 Hold
60
﹤0.01% 858
2026
Q1
$359 Buy
+60
New +$451 ﹤0.01% 1012
2025
Q4
Sell
-252
Closed -$2.69K 1113
2025
Q3
$2.69K Buy
252
+78
+45% +$765 ﹤0.01% 648
2025
Q2
$1.68K Sell
174
-3
-2% -$31 ﹤0.01% 733
2025
Q1
$2.64K Buy
177
+27
+18% +$415 ﹤0.01% 660
2024
Q4
$2.24K Sell
150
-10
-6% -$163 ﹤0.01% 689
2024
Q3
$3.06K Buy
160
+19
+13% +$394 ﹤0.01% 651
2024
Q2
$2.92K Buy
141
+36
+34% +$715 ﹤0.01% 637
2024
Q1
$1.97K Sell
105
-149
-59% -$2.56K ﹤0.01% 707
2023
Q4
$3.66K Buy
+254
New +$3.46K ﹤0.01% 636

Other funds holding OGN

Bruce G. Allen Investments's OGN Position: Q2 2026 in Review

Bruce G. Allen Investments held its Organon & Co (OGN) position steady in Q2 2026 at 60 shares worth $812. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Bruce G. Allen Investments first reported a position in OGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.66K in Q4 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Bruce G. Allen Investments held 60 shares of Organon & Co worth $812 as of Q2 2026.
  • Bruce G. Allen Investments left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #858 holding.
  • Bruce G. Allen Investments first reported a position in Organon & Co in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's Organon & Co position peaked at $3.66K in Q4 2023.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.